Drugs / THB001
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT05510843 | Sep 2022 → Mar 2023 | cold urticaria | Third Harmonic Bio, Inc. | Terminated | No outcome recorded Stop: Enrollment |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | THB001 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05510843 ↗ |
| Route | Oral | “100 mg capsules for oral administration” NCT05510843 ↗ |